Invokana

Invokana (canagliflozin) is a brand-name form of canagliflozin, a drug used to help manage type 2 diabetes. It belongs to a class called SGLT2 inhibitors, which work by helping the kidneys remove excess glucose from the bloodstream through urine. This process lowers blood sugar levels and supports better long-term glucose control.
Beyond blood sugar management, canagliflozin has shown additional health benefits. Research indicates it can support heart health by reducing the risk of certain cardiovascular complications in people with type 2 diabetes who also have heart disease. It has also been linked to kidney protection, helping slow the progression of diabetic kidney damage in some individuals. Because of these combined effects, it is often considered a multi-benefit therapy for people managing diabetes with related health risks.
Common side effects may include increased urination, thirst, and a higher chance of urinary or genital infections due to the increased sugar in urine. Some people may also experience dizziness, especially when standing up quickly, because of mild fluid loss. Rare but serious effects can include dehydration, low blood pressure, and changes in kidney function, making regular health monitoring important.
Invokana is usually taken once daily, often before the first meal of the day. Its effectiveness is strongest when combined with healthy lifestyle habits such as balanced nutrition, regular physical activity, weight management, and routine blood sugar monitoring. When used as part of a comprehensive care plan, canagliflozin can play a valuable role in long-term diabetes management and overall metabolic health.